首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
floating β lipoprotein相关文献:
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J.
J Clin Invest. 1993 Aug;92(2):883-93. doi: 10.1172/JCI116663.
PMID:8349823
Lipids and Cardiovascular Risk with CKD.
Afshinnia F, Pennathur S.
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):5-7. doi: 10.2215/CJN.13531119. Epub 2019 Dec 12.
PMID:31846933
Lipoprotein carriers of microRNAs.
Michell DL, Vickers KC.
Biochim Biophys Acta. 2016 Dec;1861(12 Pt B):2069-2074. doi: 10.1016/j.bbalip.2016.01.011. Epub 2016 Jan 26.
PMID:26825691
Diabetic dyslipidemia: evaluation and mechanism.
Yanai H, Hirowatari Y, Yoshida H.
Glob Health Med. 2019 Oct 31;1(1):30-35. doi: 10.35772/ghm.2019.01007.
PMID:33330752
Biochemistry, Low Density Lipoprotein.
Venugopal SK, Anoruo M, Jialal I.
2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
PMID:29763186
Lipoprotein heterogeneity and apolipoprotein B metabolism.
Packard CJ, Shepherd J.
Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3542-56. doi: 10.1161/01.atv.17.12.3542.
PMID:9437204
IDL, VLDL, chylomicrons and atherosclerosis.
Nordestgaard BG, Tybjaerg-Hansen A.
Eur J Epidemiol. 1992 May;8 Suppl 1:92-8. doi: 10.1007/BF00145358.
PMID:1505659
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Taskinen MR, Matikainen N, Björnson E, Söderlund S, Inkeri J, Hakkarainen A, Parviainen H, Sihlbom C, Thorsell A, Andersson L, Adiels M, Packard CJ, Borén J.
Diabetologia. 2023 Dec;66(12):2307-2319. doi: 10.1007/s00125-023-06008-0. Epub 2023 Sep 29.
PMID:37775612
Postprandial inflammation: targeting glucose and lipids.
de Vries MA, Klop B, Janssen HW, Njo TL, Westerman EM, Castro Cabezas M.
Adv Exp Med Biol. 2014;824:161-70. doi: 10.1007/978-3-319-07320-0_12.
PMID:25038999
Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia.
Singh S, Zahoor I, Sharma N, Behl T, Kanojia N, Sehgal A, Mohan S, Almoshari Y, Salawi A, Aleya L, Bungau S.
Environ Sci Pollut Res Int. 2022 Nov;29(51):76514-76531. doi: 10.1007/s11356-022-23043-3. Epub 2022 Sep 26.
PMID:36161571
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3